ClinicalTrials.Veeva

Menu

Effect of Nocturnal Administration of Anti-hypertensive Medications in NoN-dippers

Yonsei University logo

Yonsei University

Status and phase

Completed
Phase 4

Conditions

Hypertension

Treatments

Drug: Valsaltan, amlodipine

Study type

Interventional

Funder types

Other

Identifiers

NCT01091753
4-2007-0440

Details and patient eligibility

About

The purpose of this study is to determine the effect of nocturnal administration of Anti-hypertensive medications in Non-dippers.

Efficacy variables.

  1. ECHO
  2. 24hr. horter
  3. IMT
  4. BUN/crea, urine analysis (microalbulinuria
  5. Cardio vascular event. "

Enrollment

28 patients

Sex

All

Ages

18 to 70 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Essential hypertension (stage 1-2)
  2. 24hr. holer : non-dipper
  3. Age 18 ~70.

Exclusion criteria

  1. Any known malignant disease
  2. Renal failure , creatinine >2.0mg/dl
  3. Liver disease

Trial design

28 participants in 2 patient groups, including a placebo group

morning administration group
Placebo Comparator group
Treatment:
Drug: Valsaltan, amlodipine
nocturnal administration group
Experimental group
Treatment:
Drug: Valsaltan, amlodipine

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems